ArticleFrontiers in oncology2025
Fully-connected network-based prediction model for lymph node metastasis in clinical early-stage endometrial cancer: development and validation in two centers.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictors of sentinel lymph node mapping failure in endometrial cancer: a retrospective multicenter study.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The risk of lymph node metastasis significantly influences the choice of surgical strategy for patients with early-stage endometrial cancer. While sentinel lymph node dissection can be considered in clinically early-stage endometrial cancer, lymph node evaluation might be omitted in patients with very low risk of lymph node metastasis. This study aims to develop a predicting model for lymph node metastasis in these patients, identifying potential metastases as thoroughly as possible to provide clinicians with a preoperative reference that helps in decisions about surgical procedures and treatments. Materials and Methods: We retrospectively collected data from 4,400 cases across two centers to develop a predictive model for lymph node metastasis in patients with early-stage endometrial cancer using a Fully-connected (FC) Network. Internal validation was performed, and an additional 750 cases were prospectively collected from subcenter 1 for external validation. After comparing commonly used imputation methods, missing values were filled using the K-Nearest Neighbors (KNN) for the highest sensitivity of the model. The model was evaluated by precision, sensitivity, specificity, and overall accuracy. The performance of the model was compared to other machine-learning models. The risk stratification was divided by 1%, 5%, and 25%. Combining the results of Logistic regression, the pathological subtype-specific nomograms were constructed and served as alternatives to the FC Network. Results: The FC Network achieved the highest sensitivity-0.982 in internal validation and 0.900 in external validation-demonstrating exceptional performance in identifying patients with probable lymph node metastasis compared to other machine-learning methods. Considering the prognostic implications of histological subtypes, subtype-specific nomograms were constructed, achieving AUCs of 0.810/0.784/0.834 for non-aggressive and 0.726/0.810/0.650 for aggressive subtypes across the training, internal, and external cohorts. Conclusions: The model proposed in this study can be used for risk prediction of lymph node metastasis in early-stage patients. The nomograms can be used as a feasible and easily used alternative for the model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.